Subscribe To Our Free Newsletter |
Strides Pharma Global receives USFDA approval for Sucralfate Oral Suspension
Strides Pharma Science announced that its stepdown wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for the generic version of Sucralfate Oral Suspension, 1gm/10 mL, from the United States Food & Drug Administration (USFDA).